CJC-1295 (without DAC) 10 mg is a modified GHRH analogue under investigation in growth-hormone pulse research. Without the DAC modification, it produces a shorter-acting pulse profile compared to the DAC version.
Research Profile
- Modified GHRH analogue (no DAC)
- Studied in pulsatile GH release and IGF-1 research
- Often researched in combination with Ipamorelin
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: CJC-1295 (without DAC)
- Dosage: 10 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
